Gradient Investments LLC Cuts Position in The Cooper Companies, Inc. $COO

Gradient Investments LLC trimmed its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 22.2% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 31,829 shares of the medical device company’s stock after selling 9,102 shares during the period. Gradient Investments LLC’s holdings in Cooper Companies were worth $2,282,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Root Financial Partners LLC raised its holdings in shares of Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after buying an additional 162 shares during the period. SJS Investment Consulting Inc. lifted its stake in Cooper Companies by 107.5% during the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after acquiring an additional 187 shares in the last quarter. Elevation Wealth Partners LLC boosted its holdings in Cooper Companies by 1,136.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock valued at $29,000 after acquiring an additional 375 shares during the period. CYBER HORNET ETFs LLC purchased a new position in Cooper Companies during the 2nd quarter valued at about $36,000. Finally, MUFG Securities EMEA plc acquired a new position in Cooper Companies in the 2nd quarter valued at about $42,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $74.23 on Monday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The company has a market cap of $14.48 billion, a price-to-earnings ratio of 62.91, a price-to-earnings-growth ratio of 1.94 and a beta of 0.83. The stock’s 50-day moving average is $69.64 and its two-hundred day moving average is $71.44. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter last year, the business posted $0.96 EPS. The business’s quarterly revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have issued reports on COO shares. Needham & Company LLC cut their price target on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a research note on Friday, June 5th. Weiss Ratings cut shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. Wells Fargo & Company reaffirmed a “sell” rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a report on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $81.36.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.